All CompaniesPharmaceutical Preparations
ABBV
ABBVIE INC.$257.41updated Jul 31, 2026
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Total Trades
37
Politicians Trading
13
Last Traded
Jun 2, 2026
Price history
Congressional Trades
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Ro KhannaD | Jul 6, 2026 | Jun 2, 2026 | Buy | $1,001 - $15,000 | +19.50% |
| Ro KhannaD | Jun 9, 2026 | May 15, 2026 | Buy | $15,001 - $50,000 | +22.35% |
| Josh GottheimerD | Jun 3, 2026 | May 5, 2026 | Sell | $1,001 - $15,000 | +24.89% |
| Ro KhannaD | Jun 9, 2026 | May 1, 2026 | Buy | $15,001 - $50,000 | +24.59% |
| Ro KhannaD | May 11, 2026 | Apr 13, 2026 | Sell | $15,001 - $50,000 | +24.67% |
| Alan ArmstrongR | Jul 21, 2026 | Mar 27, 2026 | Buy | $15,001 - $50,000 | +22.93% |
| Julie JohnsonD | Jan 15, 2026 | Dec 18, 2025 | Sell | $1,001 - $15,000 | +15.52% |
| Julia LetlowR | Jan 13, 2026 | Dec 8, 2025 | Sell | $1,001 - $15,000 | +15.37% |
| Julie JohnsonD | Dec 11, 2025 | Nov 13, 2025 | Sell | $1,001 - $15,000 | +10.81% |
| Lisa C. McClainR | Nov 21, 2025 | Oct 31, 2025 | Sell | $1,001 - $15,000 | +18.06% |
| Lisa C. McClainR | Nov 21, 2025 | Oct 30, 2025 | Buy | $1,001 - $15,000 | +12.80% |
| Lisa C. McClainR | Nov 21, 2025 | Oct 30, 2025 | Sell | $1,001 - $15,000 | +12.80% |
| John BoozmanR | Sep 12, 2025 | Aug 22, 2025 | Sell | $1,001 - $15,000 | +22.23% |
| Julie JohnsonD | Sep 11, 2025 | Aug 14, 2025 | Sell | $1,001 - $15,000 | +25.76% |
| John BoozmanR | Sep 12, 2025 | Aug 11, 2025 | Sell | $1,001 - $15,000 | +29.59% |
| Marjorie Taylor GreeneR | Aug 15, 2025 | Aug 4, 2025 | Buy | $1,001 - $15,000 | +30.54% |
| Lisa C. McClainR | Aug 13, 2025 | Jul 22, 2025 | Buy | $1,001 - $15,000 | +37.57% |
| Lisa C. McClainR | Aug 13, 2025 | Jul 22, 2025 | Sell | $1,001 - $15,000 | +37.57% |
| Ritchie TorresD | Aug 20, 2025 | Jul 11, 2025 | Sell | $1,001 - $15,000 | +33.75% |
| Lisa C. McClainR | Aug 13, 2025 | Jun 17, 2025 | Buy | $1,001 - $15,000 | +38.78% |
| Josh GottheimerD | Jun 11, 2025 | May 22, 2025 | Buy | $1,001 - $15,000 | +41.02% |
| Robert BresnahanR | Jun 9, 2025 | May 15, 2025 | Buy | $1,001 - $15,000 | +41.68% |
| Marjorie Taylor GreeneR | May 6, 2025 | May 5, 2025 | Buy | $1,001 - $15,000 | +31.28% |
| Julia LetlowR | Jan 13, 2026 | Apr 28, 2025 | Buy | $1,001 - $15,000 | +33.83% |
| Jefferson ShreveR | May 8, 2025 | Apr 17, 2025 | Sell | $50,001 - $100,000 | +48.80% |
| Josh GottheimerD | May 14, 2025 | Apr 17, 2025 | Sell | $1,001 - $15,000 | +48.80% |
| Robert BresnahanR | May 8, 2025 | Apr 8, 2025 | Sell | $1,001 - $15,000 | +46.53% |
| Jared MoskowitzD | May 9, 2025 | Apr 7, 2025 | Buy | $1,001 - $15,000 | +37.98% |
| Dwight EvansD | Apr 17, 2025 | Apr 3, 2025 | Sell | $1,001 - $15,000 | +27.66% |
| Josh GottheimerD | May 14, 2025 | Apr 3, 2025 | Buy | $1,001 - $15,000 | +27.66% |
| Josh GottheimerD | May 14, 2025 | Apr 1, 2025 | Buy | $1,001 - $15,000 | +24.79% |
| Marjorie Taylor GreeneR | Mar 19, 2025 | Mar 17, 2025 | Buy | $1,001 - $15,000 | +20.02% |
| Robert BresnahanR | Mar 27, 2025 | Feb 25, 2025 | Buy | $1,001 - $15,000 | +26.09% |
| Jefferson ShreveR | Mar 9, 2025 | Feb 24, 2025 | Buy | $50,001 - $100,000 | +26.13% |
| Julia LetlowR | Jan 13, 2026 | Jan 24, 2025 | Sell | $1,001 - $15,000 | +51.15% |
| Jared MoskowitzD | Feb 10, 2025 | Jan 15, 2025 | Buy | $1,001 - $15,000 | +50.22% |
| Jared MoskowitzD | Feb 10, 2025 | Jan 15, 2025 | Buy | $1,001 - $15,000 | +50.22% |